|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9011 USD | -.--% |
|
-.--% | - |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 89.99B | 116B | 85.12B | 115B | 125B | |||||
Other Revenues, Total | 10.55B | 10.01B | 12.66B | 17.93B | 22.98B | |||||
Total Revenues | 101B | 126B | 97.77B | 133B | 148B | |||||
Cost of Goods Sold, Total | 56.8B | 69.4B | 63.47B | 97.69B | 120B | |||||
Gross Profit | 43.74B | 56.66B | 34.3B | 35.08B | 27.77B | |||||
Selling General & Admin Expenses, Total | 21.39B | 22.21B | 15.25B | 26.33B | 23.04B | |||||
Provision for Bad Debts | - | - | 2.19B | 64M | -25M | |||||
Depreciation & Amortization - (IS) | 15.14B | 18.37B | 18.11B | 23.71B | 28.85B | |||||
Other Operating Expenses | 3.07B | 5.01B | 4.26B | 9.37B | 9.78B | |||||
Other Operating Expenses, Total | 39.6B | 45.59B | 39.81B | 59.48B | 61.64B | |||||
Operating Income | 4.14B | 11.08B | -5.51B | -24.39B | -33.87B | |||||
Interest Expense, Total | -2.81B | -4.19B | -12.01B | -16.76B | -27.98B | |||||
Interest And Investment Income | 340M | 969M | 1.46B | 4.18B | 5.48B | |||||
Net Interest Expenses | -2.47B | -3.22B | -10.55B | -12.57B | -22.5B | |||||
Income (Loss) On Equity Invest. | -19.89B | -21.17B | -16.99B | 684M | 5.77B | |||||
Currency Exchange Gains (Loss) | 436M | -943M | 9.87B | 1.68B | -1.44B | |||||
Other Non Operating Income (Expenses) | 4.6B | -1.1B | -302M | 1.51B | -37.38B | |||||
EBT, Excl. Unusual Items | -13.19B | -15.36B | -23.49B | -33.09B | -89.43B | |||||
Impairment of Goodwill | -7.05B | - | -9.68B | - | -11.24B | |||||
Gain (Loss) On Sale Of Investments | -168M | 2.45B | -99M | -1.23B | -810M | |||||
Gain (Loss) On Sale Of Assets | 1.3B | - | -270M | 92M | - | |||||
Asset Writedown | -285M | -1.71B | -1.05B | - | - | |||||
Other Unusual Items | - | - | 5.1B | 19M | 50M | |||||
EBT, Incl. Unusual Items | -19.39B | -14.63B | -29.5B | -34.21B | -101B | |||||
Income Tax Expense | 1.83B | 1.07B | 3.15B | 83M | -1.14B | |||||
Earnings From Continuing Operations | -21.23B | -15.7B | -32.65B | -34.29B | -100B | |||||
Earnings Of Discontinued Operations | - | - | 28.74B | - | 5.34B | |||||
Net Income to Company | -21.23B | -15.7B | -3.91B | -34.29B | -94.95B | |||||
Minority Interest | 305M | 204M | 766M | 575M | -548M | |||||
Net Income - (IS) | -20.92B | -15.49B | -3.14B | -33.72B | -95.5B | |||||
Net Income to Common Incl Extra Items | -20.92B | -15.49B | -3.14B | -33.72B | -95.5B | |||||
Net Income to Common Excl. Extra Items | -20.92B | -15.49B | -31.88B | -33.72B | -101B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -95.24 | -68.59 | -13.9 | -149.09 | -422.27 | |||||
Basic EPS - Continuing Operations | -95.24 | -68.59 | -140.97 | -149.09 | -445.86 | |||||
Basic Weighted Average Shares Outstanding | 220M | 226M | 226M | 226M | 226M | |||||
Net EPS - Diluted | -95.24 | -68.59 | -13.9 | -149.09 | -422.27 | |||||
Diluted EPS - Continuing Operations | -95.24 | -68.59 | -140.97 | -149.09 | -445.86 | |||||
Diluted Weighted Average Shares Outstanding | 220M | 226M | 226M | 226M | 226M | |||||
Normalized Basic EPS | -36.14 | -41.59 | -61.53 | -88.9 | -249.56 | |||||
Normalized Diluted EPS | -36.14 | -41.59 | -61.53 | -88.9 | -249.56 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 10.57B | 18.48B | 3.17B | -12.34B | -18.67B | |||||
EBITA | 6.69B | 13.52B | -2.98B | -20.67B | -29.71B | |||||
EBIT | 4.14B | 11.08B | -5.51B | -24.39B | -33.87B | |||||
EBITDAR | 10.99B | - | - | - | - | |||||
Total Revenues (As Reported) | 101B | 126B | 97.77B | 133B | 148B | |||||
Effective Tax Rate - (Ratio) | -9.45 | -7.32 | -10.68 | -0.24 | 1.13 | |||||
Total Current Taxes | 4.24B | 3.5B | 2.03B | -405M | -1.97B | |||||
Total Deferred Taxes | -2.41B | -2.43B | 237M | 488M | 822M | |||||
Normalized Net Income | -7.94B | -9.39B | -13.92B | -20.1B | -56.44B | |||||
Interest on Long-Term Debt | 2.81B | 4.19B | 1.18B | 16.76B | 27.98B | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 19.99B | 20.71B | 14.02B | 24.64B | 22.06B | |||||
Selling and Marketing Expenses | 19.99B | 20.71B | 14.02B | 24.64B | 22.06B | |||||
General and Administrative Expenses | 973M | 1.5B | 1.23B | 1.69B | 982M | |||||
Research And Development Expense From Footnotes | 894M | 859M | 690M | 4.31B | 4.35B | |||||
Net Rental Expense, Total | 422M | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | 214M | - | - | - | - | |||||
Imputed Operating Lease Depreciation | 208M | - | - | - | - | |||||
Stock-Based Comp., COGS (Total) | 1.77B | 2.09B | 5.06B | 1.11B | 128M | |||||
Stock-Based Comp., Other (Total) | - | - | - | -2.21B | 98M | |||||
Total Stock-Based Compensation | 1.77B | 2.09B | 5.06B | -1.1B | 226M |
- Stock Market
- Equities
- MLRYY Stock
- Financials VK Company Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















